Dr. Michael Argenziano, MD

Dr. Argenziano practices at Stamford Hospital in Stamford, Connecticut.

Dr. Argenziano's NPI, 1922042332, was assigned on June 15, 2006. Dr. Argenziano graduated from Vagelos College of Physicians and Surgeons in 1992. Dr. Argenziano holds New York license 199030.

Dr. Argenziano's primary practice is Stamford Hospital, at 1 Hospital Plz, Stamford, CT 06902 in Western Ct County. The practice phone is (203) 276-1000.

Dr. Argenziano's primary practice is Stamford Hospital in Stamford, Connecticut. Dr. Argenziano is also affiliated with Stamford Hospital. The medical group on file is ColumbiaDoctors. Dmand AI also links Dr. Argenziano to 2 more hospitals, 4 group practices and clinics, 4 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Argenziano practices, 8 sites in all. Vendor and product names are available with a free account.

Thoracic surgery (cardiothoracic vascular surgery) is Dr. Argenziano's primary specialty in the NPI Registry, under taxonomy code 208G00000X. Dr. Argenziano is board certified in thoracic and cardiac surgery by the American Board of Thoracic Surgery. Dmand AI has Dr. Argenziano's licenses on file in 7 states: New York, Florida, New Jersey, Connecticut, North Carolina, South Carolina and Virginia.

Dmand AI lists heart bypass surgery and heart valve surgery among the conditions Dr. Argenziano treats.

CMS data shows 76 Medicare services from Dr. Argenziano across 5 procedure codes in 2024, for 74 Medicare patients. Medicare paid $32,470 for them.

CMS counts 74 Medicare patients who saw Dr. Argenziano in 2024. The largest group is 75 to 84, with 31 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.45, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Argenziano's median patient age at 71, with 41% women.

In 2024, Dr. Argenziano wrote 16 Medicare Part D claims. 81% of them were for generic drugs. They cover 1 drug, with $270 in total drug cost. In 2018, CMS named 35 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Argenziano for performance year 2024, reported through an alternative payment model (APM). Dr. Argenziano accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Argenziano as offering telehealth. CMS counts 29 procedures of coronary artery bypass graft (cabg) by Dr. Argenziano, more than 82% of the clinicians it reports for that procedure.

Dmand AI links 171 papers to Dr. Argenziano, published from 2005 to 2025. 2020 was the busiest year, with 12. The most frequent topics are Cardiac Surgical Procedures, Postoperative Complications and Atrial Fibrillation. Dr. Argenziano has published most often in Ann Thorac Surg. Dr. Argenziano's most frequent co-authors are Craig R. Smith, MD, Isaac George, MD and Paul Kurlansky, MD.

Dmand AI links Dr. Argenziano to 6 clinical trials. 1 is still active or recruiting. Conditions studied include Mitral Valve Insufficiency, Heart Valve Diseases and Atrial Flutter. Icahn School of Medicine at Mount Sinai sponsors the most, 5.

CMS Open Payments shows 70 general payments to Dr. Argenziano from 19 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 42% of the total. Edwards Lifesciences Corporation paid the most, $6,211.

Dmand AI lists 5 awards for Dr. Argenziano, most recently America's Top Doctors in 2015.

Dr. Argenziano graduated from Vagelos College of Physicians and Surgeons in 1992. Dr. Argenziano is a member of AOA, AATS, AHA, ISHLT, NYSTS and STS.

Dr. Argenziano is in network with 20 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.